Article Text


  1. Zhang Dongying,
  2. Lu Kai,
  3. Ye Lin,
  4. Zhang Dongying
  1. Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University


    Objectives The glucagon-like peptide-1 analogue Exenatide (Ex-4) acts as aprotective factor in the cardiomyocytes damages induced by hypoxia/reoxygenation(H/R) treatment, and Ex-4 could enhance the glucose uptake of cardiomyocytes. But the relationship between those two effects was unclear. We carried out this experiment to detect Ex-4 effects on H9c2 cells damages induced by H/R, and to clarify its correlation with glucose uptake, and explore the underlying signal transduction passway.

    Methods H9c2 cells were cultures at a series of concentrations (50 nM, 100 nM, 200 nM) of Ex-4, and then subjected to H/R treatment (10/5 h). The cell vitality and the glucose concentration in the medium were measured with cell counting kit-8 (CCK-8) and glucosemeter. H9c2 cells were divided into four groups: control group (NC group), Ex-4 group, Ex-4 and p38MAPK α and β inhibitor SB203580 group (Ex-4+SB203580 group), Ex-4 and p38MAPK inhibitor BIRB796group (Ex-4+ BIRB796 group). The cells were processing with 2-NBDG, Ex-4 and inhibitors for 8 h before H/R treatment. Intracellular rate of 2-NBDG was used as a fluorescent probe for direct glucose uptake measurement. Western blot was used to analyse p38MAPK subunits proteins expression.

    Results The most suitable Ex-4 concentration and preincubation period for H9c2cells were 200 nM and 45 min. Cells treated with Ex-4 better survived with following H/R treatment and the glucose levels decreased more than that without Ex-4incubation. The fluorescence intensity of Ex-4 group was higher significantly than the NC group (p<0.05). However, the function of Ex-4 was abolished by p38MAPK inhibitor BIRB796 at a very low concentration of 0.5 µmol/l (fluorescence intensity: 415.9±57.9 vs 363.2±66.8, n=5, p<0.05) and the glucose uptake of Ex-4 groups was also attenuated by BIRB796 (316.3±52.8 au vs 386.8±30.2 au, n=5, p<0.05).While, the p38MAPK alfa and beta inhibitor SB203580 showed no inhibition of Exenatide effects on H9c2 (405.7±45.6 vs. 415.9±57.9, n=5, p>0.05) and the glucose uptake of two groups did not make a difference (521.2±75.3 au vs 491.0±41.8 au, n=5, p>0.05). Western blot proved that p38MAPKγ expression decreased in Ex-4+ BIRB796 group (0.62±0.03 vs 0.83±0.04, n=3, p<0.05), but not in Ex-4+ SB203580 group (0.79±0.03 vs. 0.83±0.04, n=3, p>0.05), when compared with Ex-4 group.

    Conclusions Ex-4 could attenuate H9c2 cells damages induced by H/R and promote glucose uptake. The p38MAPK pathway was involved in cell signal transduction, but it isp38MAPK gamma, not p38MAPKα and β mediate Ex-4′s effects.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.